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Abstract 
Today, young women infertility through chemotherapy has become a global challenge. Chemotherapy destructs the 
malignant cells by reactive oxygen species (ROS) production and inflammatory factors secretion; these factors can also 
destruct the ovarian and uterine cells.  
Infertility usually happens as a result of ovarian and uterine cells apoptosis, as well as dysfunction in these organs. 
Signaling pathways activated by chemotherapy lead to increased activation of follicles and depletion of the follicular 
pool. In addition, excessive secretion of sex hormones leads to follicles activation and infertility in women.  
Mesenchymal stem cells (MSC) use have been reported to be a great help in restoring the function of ovarian and 
uterine cells. On the other hand, they can regulate sex hormone secretion. Finally, the use of MSCs as a suitable 
treatment strategy can help restore the function of reproductive cells and treat infertility. 
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Introduction 
Gestational trophoblastic disease (GTD) is a rare 
disease characterized by disruption of trophoblastic 
tissue function and cancer formation (1). GTD has 
several types, the most common is Hydatidiform 
Mole (HM). Most of the time, HM is benign, but it 
is invasive in some patients and metastasizes to the 
other parts of the body (2, 3).  
Usually, disease progression is stopped by uterine 
evacuation; but in some patients, no changes have 
been observed in the clinical status of the patients 
despite the uterine evacuation.  
Chemotherapy is also used to prevent disease 
progression to the malignant gestational 
trophoblastic neoplasia (GTN) (3, 4).  
Methotrexate (MTX) and actinomycin D (Act-D) 
are the main chemotherapy drugs, that are 
prescribed for GTD patients to prevent GTN (5). 
Although the use of these drugs reduces the GTN 
development chances and increases the patients 
survival; the drugs side effects can affect 
subsequent pregnancies (6). 
Recent studies have shown, that chemotherapy can 
cause infertility in women, by affecting the uterus 
and ovulation (7). Therefore, in this review article, 
we investigated the effects of prophylactic 
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chemotherapy on the future pregnancies of GTD 
patients. 
Oxidative stress and infertility 
Reactive oxygen species (ROS) production is one 
of the main mechanisms of chemotherapy drugs to 
prevent cancer cells proliferation (8). Although this 
method prevents the proliferation of cancer cells, 
but it can cause infertility by affecting the uterus 
function (9). The Hedgehog signaling pathway 
(HH) is one of the regulator pathways of ROS 
production. It increases the activation of glioma-
associated oncogene homolog1 (Gli-1). Gli-1 
enhances mitochondrial membrane integrity by 
inducing the dynamin-related protein-1 (Drop-1) 
expression. Therefore, It prevents ROS production 
by enhancing mitochondrial membrane integrity 
(10, 11).  
Gli-1 activation also increases the expression of 
some antioxidant factors such as glutathione 
peroxidase (Gpx) and superoxide dismutase (SOD). 
Also, in the cross-state, activation of Gpx and SOD 
increases Gli-1 activation. In addition to Gli-1, 
Metallothionein (MT2A) also affects SOD 
expression. The results show that MT2A expression 
prevents SOD activation (12-14). Nuclear factor 
erythroid 2-related factor 2 (Nrf2) is one of the 
critical transcription factors, that play an 
antioxidant role by increasing SOD expression.  
 Therefore, it can be concluded, that Gli-1 probably 
enhances  the SOD gene transcription through Nrf2 
expression (15). Nrf2 is also one of the upstream 
factors of the Notch signaling pathway, which can  
activate it (16). Notch plays a vital role in placental 
formation, decidualization, and blood vessel 
formation by VEGF secretion (17). It also increases 
the secretion of Matrix metalloproteinase 9 
(MMP9) by activating the AKT/P38/MAPK 
pathway. MMP9 is involved in the extra villous 
trophoblastic process (EVT), and causes the 
placental formation and maternal communication 
with the fetus (18). On the other hand, ROS 
production has been shown to activate the 
ADAM17, which leads to the expression of 
involved genes in uterine fibrosis by Notch 
activation (19).  
Finally, due to the vital role of Nrf2 in the SOD 
activation as well as Notch pathway, Nrf2 
expression monitoring during chemotherapy can 
prevent infertility in HM women by inhibiting ROS 
overproduction. 
Inflammation and infertility 
Inflammation and inflammatory cytokines secretion 
are other cytotoxic mechanisms of chemotherapy 
against malignant cells (20). Although 
inflammation induction prevents the formation and 
proliferation of malignant cells in GTD patients, it 
can lead to infertility in women (21).  
The NF-kB factor is at the forefront to induce and 
spread inflammatory responses; it increases during 
the process of chemotherapy and Radiotherapy in 
women (22). Its activation leads to increased 
production of TNF-α and expression of inducible 
nitric oxide synthesis (iNOS) and cyclooxygenase2 
(COX2). iNOS expression increases the production 
of nitric oxide (NO) and the inflammatory 
cytokines secretion (23, 24). 
 TNF-α production reduces Insulin-like growth 
factor 1 (IGF-1) levels, which activates the 
ERk/P38 and PI3K/AKT pathways and prevents 
ovarian cell apoptosis (25). Following, by 
increasing the production of inflammatory 
cytokines, TGF-β as an anti-inflammatory cytokine 
also increases; it prevents them from spreading by 
suppressing inflammatory responses. It has been 
proved, that TGF-β increases TNF-α production and 
COX2 expression by activating the ERK/P38/JNK 
pathway (23, 26, 27).  
Poly (ADP-ribose) polymerase 1 (PARP-1) is 
another factor, which activates the ERK/P38/NF-kB 
pathway; Although PARP-1 inhibits iNOS, it can 
produce NO by activating eNOS. Silencing the 
information regulator 1 (SIRT1) is an inflammatory 
inhibitor, which inactivates  the NF-kB; SIRT1 
expression decreases following TNF-α production 
(28, 29). 
Another study found that SIRT1 increases NO 
production by activating PI3K/AKT (30). Wnt/beta-
catenin is another molecular pathway, that activates 
the PI3K/AKT/NF-kB inflammatory pathway (31). 
Other studies have shown that miR-1275 (a type of 
non-coding RNA) plays an anti-inflammatory role. 
This miR prevents inflammation by targeting the 
Wnt/beta-catenin pathway (32). Recent researchers 
have identified another type of noncoding RNA, 
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which is called Long non-coding RNA (LncRNA); 
they are more than 200 nucleotides in length. 
LncRNAs play essential roles to control the cellular 
processes, including inflammation and apoptosis, 
by regulating miRs expression (33); evaluating 
miRs expression or inducing them to prevent 
infertility during chemotherapy may be a useful 
treatment strategy in the future (Table 1). 
Finally, according to the pivotal role of ERk/P38 
and PI3K/AKT pathways in inflammation due to 
NF-kB activation, targeting the cited pathways can 
prevent inflammation-induced infertility in women. 
 
 


















Reduce IL-8 secretion by targeting the NF-
kB signaling 
(36, 37) 
LncRNA-h19 miR-124-3p Up regulation 





miR-128-3p Up regulation 
Cause TNF-α secretion, that leads to 







Inhibit TNF-α secretion by reduced 




miR‐18b‐5p Up regulation 
-Cause inflammation by activating the 
PI3K/AKT and inflammatory cytokines 
(43, 44) 
  Abbreviations: LncRNA: Long non-coding RNA; COX-2: Cyclooxygenase-2; NF-kB: Nuclear Factor kappa-light-
chain-enhancer of activated B cell. 
 
Premature ovarian failure 
Premature ovarian failure (POF) is one of the 
leading causes of infertility in young women. So 
far, many factors have been mentioned in relation to 
POF incidence, including environmental and 
genetic factors. Recently, chemotherapy has been 
considered a significant cause of POF (45, 46). 
Eventually, chemotherapy leads to POF in young 
women with GTN and cervical cancer. Many 
signaling pathways associated with POF, have been 
identified to be influenced by chemotherapy (47, 
48); they activate follicles and eventually, the 
follicular pool depletes.  
Two main involved pathways in the follicle 
activation include PI3K/AKT and Hippo. The 
PI3K/AKT pathway leads to mTOR activation, 
which activates the 40s ribosomal protein S6 
(RPS6) and eukaryotic translation initialization 
factor 4E (EIF4E); it increases the follicles 
activation (49). mTOR also causes myeloid-derived 
suppressor cells (MDSCs) to accumulate in the 
ovary. Excessive accumulation of MDSC increases 
ROS production (50, 51).  
Studies have suggested that using Melatonin as an 
antioxidant will reduce ROS and prevent POF; it 
reduces mTOR and PI3K/AKT activity by 
interacting with MT1. Given that, mTOR causes the 
accumulation of MDSCs inside the ovaries and 
leads to ROS production; probably Melatonin 
prevents the accumulation of MDSCs in the ovaries 
by inhibiting mTOR (52-54). 
PI3K/AKT also activates FOXO3a. FOXO3a plays 
an essential role in the Dormancy of follicles; it 
inhibits the cell cycle of follicles by increasing P27 
expression (55, 56). On the other hand, it has been 
shown, that GADD45 expression has increased in 
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POF patients under chemotherapy (57). According 
to the GADD45 role to stop the cell cycle by 
inhibiting CDC2/cyclinB1, and since FOXO3a also 
stops the cell cycle of follicles, it can be argued that 
FOXO3a inhibits follicles proliferation by inducing 
GADD45 expression. 
Finally, targeting PI3K/AKT and mTOR pathways 
as the main pathways for POF can be a good 
strategy to prevent infertility in young women 
undergoing chemotherapy. Many efforts are being 
made to treat POF and many strategies have been 
used to prevent and treat patients. One of these is 
the use of mesenchymal stem cells (MSCs), which 
are used to treat many diseases due to their potential 
differentiation. In POF, MSCs regenerate the 
follicles pool by inducing proliferation and repair of 
damaged ovarian tissues. MSCs also reduce 
granulosa cell apoptosis, follicular atresia, and 
ovarian microenvironment improvement. They 
improve ovarian function through a variety of 
pathways (Table 2).  
The use of MSCs has been shown to inhibit 
PI3K/AKT signaling, as well as immune cells 
stimulation prevention. On the other hand, these 
cells can increase the function of ovarian cells by 
reducing the apoptosis of granulosa cells. Finally, 
the use of MSCs as a new treatment can provide 
new approaches to prevent infertility in young 
patients (Table 2).  
 
Table 2. Summary of MSCs application for POF treatment. 
Authors Source Stem Cell Mechanism Outcome Ref. 
Zheng et al. Umbilical cord 
-Reduce FSH secretion 
-Reduce caspase 3 
expression 
-Increase NGF and TrkA 
expression 
-Restore ovarian tissue 
- Inhibit POF progression 
(58) 




-Increase FSHR, VEGF 
and IGF expression 
-Restore the H2O2 
function 
-Restore ovarian function by 
angiogenesis and hormone secretion 
(59) 
Yin et al. Umbilical cord 
-Increase HO-1 expression 
-Activation of JNK/Bcl-2 
signaling pathway 
-Increase T regulatory cell 
-Restore ovarian function by 
reducing inflammation and apoptosis 
(60) 
Huang et al. Fetal liver 
-Increase the expression of 
MT1, JNK1, AMPK 
-Restore the ovarian function by 
inhibition of apoptosis and ROS 
production 
(61) 
Yang et al. Bone marrow 
-Increase miR-144-5p 
-Reduce PI3K/AKT 
activation by PTEN 
inhibition 
-Increase ovarian function by 
granulosa cell apoptosis 
(62) 
Guo et al. Menstrual blood 
-Upregulation of CDC2, 
CyclinB1 
-Down regulation of 
GADD45b 
-Restore the ovarian function by 
increased proliferation of granulosa 
cells 
(63) 
Abbreviations: POF: Premature ovarian failure; FSH: Follicle-stimulating hormone; NGF: nerve growth factor; TrKA: 
high-affinity nerve growth factor receptor; VEGF: Vascular endothelial growth factor; IGF: Insulin growth factor; HO-1: 
Heme oxygenase-1; PTEN: Phosphatase and tensin homolog.  
 
Conclusion 
Finally, it can be said that chemotherapy improves 
the clinical condition of cancer patients, especially 
young women; also, it increases the incidence of 
infertility. Based on this fact, it can be said that 
identifying the molecular pathways involved in the 
apoptosis of ovarian and uterine cells, can be used 
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as a prophylactic and therapeutic strategy for 
infertility. Also, since MSCs can repair damaged 
cells and regulate sex hormones secretion, and 
ultimately restore ovarian function, they can be 
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